PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Rebif, Teva Brand
See also: Interferon beta 1a

What is Interferon beta-1a Subcutaneous Injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week. Read more...Click to read more below


Reasons Taken

1014 patients in the community are taking or have taken Interferon beta-1a Subcutaneous Injection.

Reason # Patients Percentage of patients
Slow my MS progress 878 90%
Other 39 4%
Stiffness/spasticity 14 1%
Fatigue 13 1%
disease-related symptoms 10 1%
Don't know 4 <1%
General health 4 <1%
Pain 2 <1%
Excessive daytime sleepiness (somnolence) 1 <1%
Balance issues 1 <1%
Brain fog 1 <1%
Anxiety 1 <1%
Emotional lability 1 <1%
Mobility 1 <1%
Treat Parkinson's 1 <1%
Depression 1 <1%

Dosages

Based on the patients currently taking Interferon beta-1a Subcutaneous Injection.

Top 10 (Show all)

All (Show Top 10)

  0 - day 0 mcg day 0 mg day 0 day 0 - none 0 mcg none 0 mg none 0 mcg week 0 mg week 0 week 0.14 mcg week 0.44 mg week 0.5 mL week 0.5 mcg week 0.5 mg week 0.22 mg day 0.25 mcg day 0.25 mg day 1 g week 1 week 0.3 mcg day 0.3 mg day 1.1 week 0.44 mcg week 0.5 mcg week 0.44 mcg day 0.44 mg day 0.44 day 0.5 mcg day 0.5 mg day 0.8 mcg week 0.75 mg day 1 mcg week 3 mcg week 3 mg week 3 week 0.5 mcg day 1 g day 1 mcg day 1 mg day 1 day 2.2 mcg week 8.8 mcg week 3 mcg week 3 mcg day 3 mg day 4.4 mcg week 15 mcg week 20 mg week 22 mcg week 22 mg week 10 mcg week 30 mcg week 30 mg week 8.8 mg day 33 mg week 10 day 12 mcg week 44 mcg week 44 mg week 44 week 8 mcg day 60 mg week 22 mcg week 66 mcg week 66 mg week 20 mcg day 20 mg day 22 mcg day 22 mg day 22 day 25 mg day 88 mcg week 30 mcg week 33 mcg week 30 mcg day 112 mcg week 40 mcg week 120 mg week 126 mcg week 18.85708 mcg day 44 mcg week 132 mcg week 132 mg week 132 week 134 mcg week 40 mcg day 40 day 41 mcg day 43 mg day 152 mg week 22 mcg day 44 g day 44 mcg day 44 mg day 44 day 100 mcg week 300 week 44 mcg day 307.993840123198 mcg week 132 mcg week 395.990760184796 mcg week 138 mcg week 144 mcg week 125 day 132 mcg day 461.990760184796 mcg week 144 mg day 200 mcg week 200 mcg day 200 mg day 923.981520369593 mcg week 923.981520369593 mg week 321 mcg week 300 mg day 200 g day 500 mcg day
  1 Number of Patients: 1 18 Number of Patients: 18 3 Number of Patients: 3 22 Number of Patients: 22 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 33 Number of Patients: 33 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 9 Number of Patients: 9 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 24 Number of Patients: 24 17 Number of Patients: 17 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 123 Number of Patients: 123 33 Number of Patients: 33 17 Number of Patients: 17 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 2 Number of Patients: 2 53 Number of Patients: 53 90 Number of Patients: 90 25 Number of Patients: 25 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Interferon beta-1a Subcutaneous Injection or how long patients were taking Interferon beta-1a Subcutaneous Injection before stopping.

Currently taking Interferon beta-1a Subcutaneous Injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
12
28
62
100
109
221

Stopped taking Interferon beta-1a Subcutaneous Injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
10
31
37
51
54
88
Why Patients Stopped Taking Interferon beta-1a Subcutaneous Injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 150 55% Side effects too severe: 55%
Did not seem to work 79 29% Did not seem to work: 29%
Doctor's advice 59 22% Doctor's advice: 22%
Other 43 16% Other: 16%
Expense 11 4% Expense: 4%
Personal research 10 4% Personal research: 4%
Not indicated 10 4% Not indicated: 4%
Course of treatment ended 4 1% Course of treatment ended: 1%

Patient Reported Evaluations

Results from 27 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 16% 4
Moderate 16% 4
Slight 8% 2
None 16% 4
Can't tell 44% 11

Slow my MS progress

Side-effects (as an overall problem)

Severe 15% 4
Moderate 41% 11
Mild 37% 10
None 7% 2

Top reported side-effects include: injection site redness, Muscle ache, whole body, Chills/fever

Summary results are based on 27 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 27)

  • Diamondlil58
    Sensation: moderate
    Overall: moderate
    Cognition: moderate
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
    See profile
  • Diamondlil58
  • by Diamondlil58
    Aug 18, 2008
  • EfficacyCan't tell
  • Side-effectsMild
  • Slow my MS progress
Advice/Tips
Rotate injection sites and take Ibuprofen at time of injection.

  • jeannadebello23
    Flare-up: severe
    Sensation: severe
    Overall: severe
    Cognition: severe
    Vision: moderate
    Speech: severe
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
    See profile
  • jeannadebello23
  • by jeannadebello23
    Mar 23, 1990
  • EfficacyNone
  • Side-effectsSevere
  • Stiffness/spasticity

See all evaluation results for Interferon beta-1a Subcutaneous Injection



Back to top